期刊文献+

霉酚酸酯对UUO大鼠肾间质p-Smad2/3表达的影响 被引量:1

Effect of Mycophenolate Mofetil(MMF) on the Expression of p-Smad2/3 in Unilateral Ureteral Obstruction(UUO) Rats
下载PDF
导出
摘要 【目的】通过霉酚酸酯(MMF)干预单侧输尿管梗阻(UUO)大鼠模型,动态观察TGF-β1、p-Smad2/3在梗阻侧肾组织中的表达,探讨MMF对TGF-β依赖性Smad信号通路的影响。【方法】54只雄性SD大鼠随机分为假手术组(SOR组)、UUO组和MMF组。于术后d7、d14、d21每组分别处死6只大鼠。HE、PAS和Masson染色观察梗阻侧肾间质胶原相对面积和炎症细胞浸润指数的变化,免疫组化染色法观察TGF-β1和p-Smad2/3蛋白在肾间质中的表达,RT-PCR方法观察TGF-β1在肾组织中的表达。【结果】UUO组肾间质胶原相对面积、炎症细胞浸润指数、TGF-β1和p-Smad2/3蛋白表达,以及肾组织TGF-β1mRNA表达均较SOR组显著增高,MMF组各时间点与相应UUO组比均显著降低。【结论】MMF能通过抑制TGF-β依赖性Smad信号通路延缓UUO大鼠肾间质纤维化的进展。 [ObjectivelTo explore the effect of MMF on the TGF-β -depended Smad signal pathway in the obstructive renal tissue of UUO rats. [MethodslFifty-four male Sprague-Dawley rats were randomly divided into three groups: sham-operated rats (SOR) group, UUO group, MMF group. Six rats in each group were sacrificed at the 7th, 14th, 21th day after operation. The collagen area and the index of cell infiltration were observed by HE, PAS and Masson stain. The protein expressions of TGF-β1 and p-Smad2/3 in renal interstiti- um were detected by immunohistoehemistry. The mRNA expressions of TGF-β in renal tissue were observed by RT-PCR. [ResultslThe collagen area, index of cell infiltration, protein expressions of TGF-β1 and p- Smad2/3, and the mRNA expressions of TGF-β1 in group UUO were obviously higher than in group SOR. They were decreased in group MMF at each time point. [ConelusionlIn UUO rats, MMF may postpone renal interstitial fibrosis by inhibiting the TGF-β-depended Smad signal pathway.
出处 《医学临床研究》 CAS 2006年第12期1910-1913,共4页 Journal of Clinical Research
基金 湖南省自然科学基金资助课题(05JJ30059)
关键词 间质细胞 霉酚酸 大鼠 kidney stromal cells mycophenolic acid rats
  • 相关文献

参考文献2

二级参考文献13

  • 1Bradham DM, Igarashi A, Grotendorst GR. Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol, 1991, 114: 1285-1294.
  • 2Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?Matrix Biol, 2002, 21: 473-482.
  • 3Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol, 2002, 282: F933-F942.
  • 4Hishikawa K, Oemar BS, Nakaki T. Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem,2001,276: 16797-16803.
  • 5Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol, 2002, 118:211-215.
  • 6Chen Y, Blom IE, Sa S, et al. CTGF expression in mesangial cells:involvement of SMADs, MAP kinase, and PKC. Kidney Int,2002, 62:1149-1159.
  • 7Li JH, Zhu HJ, Huang XR, et al. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking smad2activation. J Am Soc Nephrol, 2002, 13: 1464-1472.
  • 8Ha H,Lee HB.Effect of high glucose on peritoneal mesothelial cell biology.Perit Dial Int,2000,20 Suppl 2:S15-S18.
  • 9Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int, 2001, 59: 461-470.
  • 10Tamaki K, Oknda S. Role of TGF-beta in the progression of renal fibrosis. Contrib Nephrol, 2003, 139: 44-65.

共引文献22

同被引文献17

  • 1汤颖,娄探奇,成彩联,彭晖,关伟明.实验性IgA肾病模型的改进[J].中山大学学报(医学科学版),2006,27(2):184-187. 被引量:108
  • 2Li XZ, Feng JT, Hu CP, et al. Does Arkadia contribute to TGF- 131-induced IgA expression through up-regulation of Smad signaling in IgA nephropathy [ J ]. Int Urol Nephrol, 2010,42 ( 3 ) : 719 -722.
  • 3Fasanarong A, Thitiarchakul S. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid depend- ent and resistant nephrotic syndrome [ J ]. J Med Assoc Thai, 2006,89 ( Suppl 2 ) : $218 -227.
  • 4Lai AS, Lai KN. Molecular basis of IgA nephropathy [ J ]. Curr Mol Med, 2005,5 (5) :475-487.
  • 5Eddy AA. Molecular insights into renal interstitial fibrosis [ J ]. J Am Soc Nephml, 1996,7 ( 12 ) : 2495-2508.
  • 6Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for ene therapy[ J]. Kidney Int, 1997,51 (5) :1388-1396.
  • 7Yoshioka K, Takemura T, Murakami K, et al. In situ expression of cytokines in IgA nephritis [ J ]. Kidney Int, 1993,44 (4) : 825- 833.
  • 8Border WA, Noble NA, ~amamoto T, et al. Antagonists of trans- forming growth factor-beta:a novel approach to treatment of glomer- ulonephritis and prevention of glomerulosclerosis [ J ]. Kidney Int, 1992,41 (3) :566-570.
  • 9Lim CS, Kim YS, Chae DW, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-betal gene with susceptibility to and progression of IgA nephropathy [ J ]. Clin Nephrol, 2005,63(2) :61-67.
  • 10Wang F, Xie X, Fan J, et al. Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy[ J]. Int Urol Nephrol, 2010, 42(3) :811-819.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部